Maternal Tolerance to Fetal Alloantigens
Maternal Tolerance to Fetal Alloantigens
批准号:
8284441
负责人:
MARGARET G PETROFF
金额:
$29.88万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-01-01 至 2015-05-31
关键词:
AddressAlloantigenAllogenicAllograftingAntigen-Presenting CellsAntigensAppearanceAtypical lymphocyteAutoimmune DiseasesCD28 geneCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCellsCharacteristicsCommunicable DiseasesDendritic CellsDevelopmentDisciplineEquilibriumEventFailureFamilyFertilityFetusFundingGoalsGraft RejectionGrantGrowthHumanImmuneImmune ToleranceImmune systemIndividualInfertilityInheritedKnowledgeLabor PresentationLeadLigandsLightLymphocyteMajor Histocompatibility ComplexMalignant NeoplasmsMapsMaternal-Fetal ExchangeMediatingMedicalMedicineMinorMinor Histocompatibility AntigensModelingMolecularMothersMusOncologistPathogenesisPhysiologicalPlacentaPositioning AttributePregnancyPropertyProteinsReactionResearchRoleSolutionsSourceSpecialistStimulusSurgeonSystemT-LymphocyteTherapeutic AgentsTimeTransgenic OrganismsTransplantationVariantY Chromosomebasecombatembryo/fetus antigenfeedingfetalin vitro Modelinsightintimate behaviormouse modelpublic health relevancereceptorresponserheumatologistsextooltrophoblast
中文摘要
描述(由申请人提供):本研究的总体目标是了解妊娠期母体对同种异体胎儿的免疫耐受机制。母体免疫系统和胎儿同种异体移植物之间的亲密关系是一种无与伦比的生理情况,其中胎儿表达的父系遗传的胎儿抗原在正常妊娠中被可靠地耐受。本文提出的研究进一步调查了先前的观察结果,即鼠和人妊娠均导致对父系遗传的胎儿同种异体抗原的高度特异性识别。这对主要和次要组织相容性抗原都适用。在这个建议中,我们将采用转基因胎儿次要组织相容性抗原与母体CD4+和CD8+淋巴细胞,特异性地反应,这种抗原的组合,以研究母体淋巴细胞反应和诱导耐受胎儿抗原的小鼠模型。我们还研究了胎儿次要组织相容性抗原在人胎盘中的表达、时间和呈递。我们的具体目标是:1。确定小鼠妊娠期间产生的mHAg特异性T细胞的表型和功能特性。2.确定妊娠期间抗原呈递细胞向T细胞展示胎儿抗原的表型和功能特性。3.探讨胎儿源性mHAg在妊娠过程中的表达及其功能意义。总的来说,这些研究将产生重要的新的见解,母体淋巴细胞对胎儿抗原的反应,导致免疫适应和母亲和胎儿的和谐共处。这一知识反过来可以为妊娠失败的发病机制提供新的线索,并证明是开发治疗药物的基础,不仅可以共同对抗不孕症,还可以对抗癌症,自身免疫性疾病和移植排斥反应。
公共卫生相关性:许多医学情况是由于对抗原的不适当的免疫耐受(如癌症)或对抗原的不适当的免疫不耐受(如妊娠失败、自身免疫性疾病和移植排斥)引起的。怀孕代表了外来“移植物”和母体免疫系统之间的完美平衡,母体免疫系统已经适应了促进胎儿的生长,而不是排斥它。了解围绕这一独特生理情况的事件将有助于了解如何缓解不孕症,癌症和自身免疫性疾病。
英文摘要
DESCRIPTION (provided by applicant): The overall goal of this research is to understand the mechanisms of maternal immune tolerance to the allogeneic fetus in pregnancy. The intimacy between the maternal immune system and the fetal allograft is an unparalleled physiological situation in which paternally inherited fetal antigens expressed by the fetus are unfailingly tolerated in normal pregnancy. The studies proposed herein further investigate previous observations that both murine and human pregnancy results in highly specific recognition of paternally- inherited fetal alloantigens. This holds true for both major and minor histocompatibility antigens. In this proposal, we will employ a murine model of a transgenic fetal minor histocompatibility antigen in combination with maternal CD4+ and CD8+ lymphocytes that specifically react to this antigen to investigate maternal lymphocyte responses and induction of tolerance to fetal antigen. We also investigate the expression, timing and presentation of fetal minor histocompatibility antigens in the human placenta. Our Specific Aims are: 1. Determine the phenotypic and functional properties of mHAg-specific T cells generated during murine pregnancy. 2. Determine the phenotypic and functional properties of antigen presenting cells displaying fetal antigen to T cells during pregnancy. 3. Investigate the expression and functional significance of fetally-derived mHAg in human pregnancy. Collectively, these studies will yield important new insights into the responses of maternal lymphocytes to fetal antigen that lead to immunological adaptation and harmonious coexistence of mother and fetus. This knowledge could in turn, give new light into the pathogenesis of pregnancy failure, and proved a basis for the development of therapeutic agents, not only co combat infertility, but also cancer, autoimmune disease and transplant rejection.
PUBLIC HEALTH RELEVANCE: Numerous medical situations arise from either inappropriate immune tolerance to antigen, such as cancer, or inappropriate immune intolerance to antigen, such as failed pregnancy, autoimmune disease, and transplantation rejection. Pregnancy represents a perfect balance of coexistence between a foreign "graft" and the maternal immune system that has adapted to promote the growth of the fetus rather than reject it. Understanding the events surrounding this unique physiological situation will yield insight on how infertility, cancer and autoimmune disease may be alleviated.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Maternal Central Immune Tolerance in Reproduction
-
批准号:10396646
-
项目类别:
-
资助金额:$39.64万
-
财政年份:2020
-
负责人:MARGARET G PETROFF
-
依托单位:
Maternal Central Immune Tolerance in Reproduction
-
批准号:10215585
-
项目类别:
-
资助金额:$39.35万
-
财政年份:2020
-
负责人:MARGARET G PETROFF
-
依托单位:
Endocrine regulation of maternal immunity in pregnancy
-
批准号:10116259
-
项目类别:
-
资助金额:$19.56万
-
财政年份:2020
-
负责人:MARGARET G PETROFF
-
依托单位:
Endocrine regulation of maternal immunity in pregnancy
-
批准号:9979498
-
项目类别:
-
资助金额:$23.48万
-
财政年份:2020
-
负责人:MARGARET G PETROFF
-
依托单位:
Maternal Central Immune Tolerance in Reproduction
-
批准号:10617856
-
项目类别:
-
资助金额:$39.96万
-
财政年份:2020
-
负责人:MARGARET G PETROFF
-
依托单位:
Shared Placenta/Tumor Antigens and Maternal Immunity
-
批准号:9316903
-
项目类别:
-
资助金额:$23.25万
-
财政年份:2017
-
负责人:MARGARET G PETROFF
-
依托单位:
INNATE AND ADAPTIVE IMMUNITY TO HCV IN HUMAN PREGNANCY
-
批准号:8654226
-
项目类别:
-
资助金额:$33.6万
-
财政年份:2014
-
负责人:MARGARET G PETROFF
-
依托单位:
INNATE AND ADAPTIVE IMMUNITY TO HCV IN HUMAN PREGNANCY
-
批准号:9021550
-
项目类别:
-
资助金额:$31.86万
-
财政年份:2014
-
负责人:MARGARET G PETROFF
-
依托单位:
Maternal Central Immune Tolerance to the Fetal-Placental Unit
-
批准号:8038448
-
项目类别:
-
资助金额:$18.0万
-
财政年份:2010
-
负责人:MARGARET G PETROFF
-
依托单位:
Maternal Central Immune Tolerance to the Fetal-Placental Unit
-
批准号:7774089
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2010
-
负责人:MARGARET G PETROFF
-
依托单位:
FUNCTIONAL COOPERATION BETWEEN TROPHOBLAST HLA-G AND B7 FAMILY
-
批准号:7699715
-
项目类别:
-
资助金额:$19.64万
-
财政年份:2008
-
负责人:MARGARET G PETROFF
-
依托单位:
HLA-G at the Maternal Fetal Interface
-
批准号:8049076
-
项目类别:
-
资助金额:$92.41万
-
财政年份:2007
-
负责人:MARGARET G PETROFF
-
依托单位:
FACULTY DEVELOPMENT AWARDS
-
批准号:7171095
-
项目类别:
-
资助金额:$9.87万
-
财政年份:2005
-
负责人:MARGARET G PETROFF
-
依托单位:
Immunomodulatory B7 Family Proteins in the Placenta
-
批准号:7159420
-
项目类别:
-
资助金额:$25.76万
-
财政年份:2004
-
负责人:MARGARET G PETROFF
-
依托单位:
Immunomodulatory B7 Family Proteins in the Placenta
-
批准号:7340194
-
项目类别:
-
资助金额:$25.17万
-
财政年份:2004
-
负责人:MARGARET G PETROFF
-
依托单位:
Maternal Tolerance to Fetal Alloantigens
-
批准号:9060528
-
项目类别:
-
资助金额:$26.74万
-
财政年份:2004
-
负责人:MARGARET G PETROFF
-
依托单位:
Immunomodulatory B7 Family Proteins in the Placenta
-
批准号:6710472
-
项目类别:
-
资助金额:$28.56万
-
财政年份:2004
-
负责人:MARGARET G PETROFF
-
依托单位:
Immunomodulatory B7 Family Proteins in the Placenta
-
批准号:7005408
-
项目类别:
-
资助金额:$26.6万
-
财政年份:2004
-
负责人:MARGARET G PETROFF
-
依托单位:
Maternal Tolerance to Fetal Alloantigens
-
批准号:8131824
-
项目类别:
-
资助金额:$29.88万
-
财政年份:2004
-
负责人:MARGARET G PETROFF
-
依托单位:
Maternal Tolerance to Fetal Alloantigens
-
批准号:7986516
-
项目类别:
-
资助金额:$31.13万
-
财政年份:2004
-
负责人:MARGARET G PETROFF
-
依托单位:
海外基金